Finance

Beta
Lists
CTVA:NYSE
Corteva Inc
$81.62
+1.91%
(+1.53) 1D
$81.87
+0.31% (+0.25)
After hours
Closed: Jun 25, 4:01:33 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTVA...
Open
$80.02
High
$81.78
Low
$79.96
Mkt. cap
54.59B
Avg. vol.
4.07M
Volume
0.00
Dividend
0.88%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
47.93
52-wk high
$85.63
52-wk low
$60.54
EPS
$1.70
Beta
0.56
Shares outstanding
668.82M
No. of employees
22K
Open
$80.02
High
$81.78
Low
$79.96
Mkt. cap
54.59B
Avg. vol.
4.07M
Volume
0.00
Dividend
0.88%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
47.93
52-wk high
$85.63
52-wk low
$60.54
EPS
$1.70
Beta
0.56
Shares outstanding
668.82M
No. of employees
22K
News stories
From sources across the web
Profile
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. Wikipedia
About Corteva Inc
CEOChuck Magro
Employees21.5K
FoundedMar 15, 2018
Headquarters-
SectorFertilizer
Websitecorteva.com
Analyst ratings
Based on 13 analysts giving stock ratings to CTVA in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CTVA in the last 3 months.
Highest
Current $81.62
$97.00 (+18.84%)
Average
$90.69 (+11.11%)
Lowest
$78.00 (-4.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Jefferies
Buy
Maintained
$97.00
+18.8%
06/18/2026
Matthew DeYoe
Bank of America Securities
Buy
Maintained
$90.00
+10.3%
06/18/2026
Vincent Andrews
Morgan Stanley
Buy
Reiterated
$95.00
+16.4%
06/17/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
$97.00
+18.8%
06/11/2026
Benjamin Theurer
Barclays
Buy
Maintained
$91.00
+11.5%
06/11/2026
Joshua Spector
UBS
Hold
Reiterated
$86.00
+5.4%
06/09/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$90.00
+10.3%
05/27/2026
Kristen Owen
Oppenheimer
Buy
Maintained
$89.00
+9%
05/07/2026
Patrick Cunningham
Citi
Hold
Maintained
$85.00
+4.1%
05/07/2026
Duffy Fischer
Goldman Sachs
Buy
Maintained
$96.00
+17.6%
05/05/2026
Edlain Rodriguez
Mizuho Securities
Buy
Maintained
$94.00
+15.2%
04/15/2026
Alexandra Yates
Argus Research
Buy
Reiterated
$91.00
+11.5%
03/30/2026
Unknown Analyst
Berenberg Bank
Hold
Reiterated
$78.00
-4.4%
03/26/2026
Jeffrey Zekauskas
J.P. Morgan
Hold
Maintained
-
-
03/10/2026
Aleksey Yefremov
KeyBanc
Hold
Maintained
-
-
02/05/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.50 / $1.18
+27.11%beat
Revenue / Est. (USD)
4.90B / 4.64B
+5.77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.46B
2.62B
3.91B
4.90B
Cost of goods sold
2.93B
1.64B
2.25B
2.37B
Cost of revenue
2.93B
1.64B
2.25B
2.37B
Research and development expenses
375.00M
351.00M
413.00M
341.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.16B
731.00M
865.00M
870.00M
Operating expense
1.70B
1.24B
1.44B
1.37B
Total operating expenses
4.63B
2.89B
3.69B
3.74B
Operating income
1.83B
-270.00M
219.00M
1.16B
Other non operating income
-7.00M
-
-34.00M
-19.00M
EBT including unusual items
1.80B
-370.00M
-530.00M
858.00M
EBT excluding unusual items
1.77B
-333.00M
103.00M
1.09B
Income tax expense
422.00M
-62.00M
7.00M
133.00M
Effective tax rate
23.39%
16.76%
-1.32%
15.50%
Other operating expenses
-
-
-
-
Net income
1.31B
-320.00M
-552.00M
720.00M
Net profit margin
20.35%
-12.22%
-14.12%
14.68%
Earnings per share
2.20
-0.23
0.22
1.50
Interest and investment income
31.00M
29.00M
44.00M
34.00M
Interest expense
-52.00M
-46.00M
-46.00M
-36.00M
Net interest expenses
-21.00M
-17.00M
-2.00M
-2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.13B
30.00M
525.00M
1.46B
Gain or loss from assets sale
-13.00M
-
-24.00M
3.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CTVA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer